Fig. 2
From: Epstein‒Barr virus and human herpesvirus 6 infection in patients with systemic lupus erythematosus
Detection of EBV latent and lytic genes expression. A PCR-Southern blotting of ths EBV latent gene EBNA2 in EBV-positive SLE samples. Lane 1: DNA molecular weight marker VIII, DIG-labeled; Lane 2: LCL(positive control); Lane 3: Ramos cells(negative controls); other Lanes: EBV-positive SLE samples. B and C PCR-Southern blotting of the EBV latent gene LMP1 and LMP2A in EBV-positive SLE samples. Lane 1: LCL (positive control); Lane 2: Ramos cells (negative controls); other Lanes: EBV-positive SLE samples. D–F RT-PCR-Southern blotting of EBV lytic gene BZLF1, BARF1 and BcLF1 in EBV-positive SLE samples. Lane1: LCL (positive control); Lane 2: Ramos cells (negative controls); other Lanes: EBV-positive SLE samples